Bevacizumab/everolimus/sorafenib/sunitinibGallbladder complications: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1545卷 / 1期

关键词：

D O I：

10.1007/s40278-015-9149-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：58 / 58

相关论文

共 50 条

[1] Erlotinib/everolimus/sorafenib/sunitinibCutaneous reactions: 6 case reports
[J]. Reactions Weekly, 2014, 1485 (1) : 18 - 18
[2] Everolimus/tacrolimusVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2023, 1959 (1) : 280 - 280
[3] Bevacizumab/dexamethasoneVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2020, 1785 (1) : 112 - 112
[4] Bevacizumab/doxorubicinCardiac toxicities: 6 case reports
[J]. Reactions Weekly, 2012, 1405 (1) : 11 - 11
[5] Aflibercept/bevacizumab/ranibizumabCataract: 6 case reports
[J]. Reactions Weekly, 2022, 1887 (1) : 30 - 30
[6] SirolimusPneumonitis treated with conversion to everolimus: 6 case reports
[J]. Reactions Weekly, 2006, 1104 (1) : 17 - 18
[7] Everolimus/octreotide/sunitinibVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2017, 1649 (1) : 118 - 118
[8] Bevacizumab/povidone-iodineVarious complications: 7 case reports
[J]. Reactions Weekly, 2015, 1577 (1) : 65 - 65
[9] Pazopanib/sorafenib/sunitinibVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2016, 1583 (1) : 861 - 861
[10] Aflibercept/bevacizumab/ranibizumabVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2022, 1904 (1) : 24 - 24

← 1 2 3 4 5 →